FDA
-
-
-
-
-
-
-
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
-
-
-
-
-
-
-
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026
-
-
-
-
-
-
-
CVRx to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
-
-
-
-
-
-
CVRx to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call on August 4, 2025
-
-
-
-
-
-
-
CVRx (CVRX) announces evidence of reduction of hospital visits after Barostim implant
-
-
-
-
-
-
-
CVRx (CVRX) Announces Positive Outpatient Payment for Barostim Procedure in 2025
-
-
-
-
-
-
-
CVRx (CVRX) Appoints Kevin Ballinger and Mitch Hill to its Board
-
322,208 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

